Skip to main content
PMC home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1996 Jan;3(1):5–9. doi: 10.1128/cdli.3.1.5-9.1996

Regulation of early complement components C3 and C4 in the synovium.

T Collins 1, J A Winkelstein 1, K E Sullivan 1
PMCID: PMC170239  PMID: 8770496

Abstract

To determine the cytokine inducibility of early complement component (C3 and C4) expression in the synovium, explant tissue was maintained in culture for 7 days. C3 and C4 production was measured by specific enzyme-linked immunosorbent assay, and RNA was evaluated by semiquantitative PCR. The effects of leukemia inhibitory factor (LIF), gamma interferon (IFN-gamma), IFN-alpha, and estrogen on C3 and C4 expression were evaluated. C3 levels were unaffected by 7 days of LIF, IFN-gamma, or IFN-alpha treatment. In contrast, C4 levels were significantly induced in synovial samples treated for 7 days with either IFN-gamma or IFN-alpha. LIF had no effect on C4 levels in this system. Estrogen was found to down-modulate the induction of expression due to IFN-gamma. These data provide evidence for cytokine regulation of C4 expression in the synovium and for estrogen modulation of those effects.

Full Text

The Full Text of this article is available as a PDF (293.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arend W. P., Dayer J. M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum. 1990 Mar;33(3):305–315. doi: 10.1002/art.1780330302. [DOI] [PubMed] [Google Scholar]
  2. Beato M. Gene regulation by steroid hormones. Cell. 1989 Feb 10;56(3):335–344. doi: 10.1016/0092-8674(89)90237-7. [DOI] [PubMed] [Google Scholar]
  3. Botto M., Lissandrini D., Sorio C., Walport M. J. Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytes. J Immunol. 1992 Aug 15;149(4):1348–1355. [PubMed] [Google Scholar]
  4. Brooimans R. A., van der Ark A. A., Buurman W. A., van Es L. A., Daha M. R. Differential regulation of complement factor H and C3 production in human umbilical vein endothelial cells by IFN-gamma and IL-1. J Immunol. 1990 May 15;144(10):3835–3840. [PubMed] [Google Scholar]
  5. Bucala R., Ritchlin C., Winchester R., Cerami A. Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med. 1991 Mar 1;173(3):569–574. doi: 10.1084/jem.173.3.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Campbell I. K., Waring P., Novak U., Hamilton J. A. Production of leukemia inhibitory factor by human articular chondrocytes and cartilage in response to interleukin-1 and tumor necrosis factor alpha. Arthritis Rheum. 1993 Jun;36(6):790–794. doi: 10.1002/art.1780360608. [DOI] [PubMed] [Google Scholar]
  7. Celada A., Klemsz M. J., Maki R. A. Interferon-gamma activates multiple pathways to regulate the expression of the genes for major histocompatibility class II I-A beta, tumor necrosis factor and complement component C3 in mouse macrophages. Eur J Immunol. 1989 Jun;19(6):1103–1109. doi: 10.1002/eji.1830190621. [DOI] [PubMed] [Google Scholar]
  8. Chazerain P., Meyer O., Kahn M. F. Rheumatoid arthritis-like disease after alpha-interferon therapy. Ann Intern Med. 1992 Mar 1;116(5):427–427. doi: 10.7326/0003-4819-116-5-427_1. [DOI] [PubMed] [Google Scholar]
  9. Chen E., Keystone E. C., Fish E. N. Restricted cytokine expression in rheumatoid arthritis. Arthritis Rheum. 1993 Jul;36(7):901–910. doi: 10.1002/art.1780360706. [DOI] [PubMed] [Google Scholar]
  10. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  11. Chu C. Q., Field M., Allard S., Abney E., Feldmann M., Maini R. N. Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. Br J Rheumatol. 1992 Oct;31(10):653–661. doi: 10.1093/rheumatology/31.10.653. [DOI] [PubMed] [Google Scholar]
  12. Conlon K. C., Urba W. J., Smith J. W., 2nd, Steis R. G., Longo D. L., Clark J. W. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer. 1990 May 15;65(10):2237–2242. doi: 10.1002/1097-0142(19900515)65:10<2237::aid-cncr2820651013>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  13. Cutolo M., Accardo S., Villaggio B., Clerico P., Bagnasco M., Coviello D. A., Carruba G., lo Casto M., Castagnetta L. Presence of estrogen-binding sites on macrophage-like synoviocytes and CD8+, CD29+, CD45RO+ T lymphocytes in normal and rheumatoid synovium. Arthritis Rheum. 1993 Aug;36(8):1087–1097. doi: 10.1002/art.1780360809. [DOI] [PubMed] [Google Scholar]
  14. Dauchel H., Julen N., Lemercier C., Daveau M., Ozanne D., Fontaine M., Ripoche J. Expression of complement alternative pathway proteins by endothelial cells. Differential regulation by interleukin 1 and glucocorticoids. Eur J Immunol. 1990 Aug;20(8):1669–1675. doi: 10.1002/eji.1830200808. [DOI] [PubMed] [Google Scholar]
  15. Falus A., Fehér K. G., Walcz E., Brozik M., Füst G., Hidvégi T., Fehér T., Merétey K. Hormonal regulation of complement biosynthesis in human cell lines--I. Androgens and gamma-interferon stimulate the biosynthesis and gene expression of C1 inhibitor in human cell lines U937 and HepG2. Mol Immunol. 1990 Feb;27(2):191–195. doi: 10.1016/0161-5890(90)90114-f. [DOI] [PubMed] [Google Scholar]
  16. Falus A. Regulation of complement biosynthesis by tissue-specific and hormonal factors. Immunol Lett. 1990 Jul;24(4):227–232. doi: 10.1016/0165-2478(90)90001-7. [DOI] [PubMed] [Google Scholar]
  17. Falus A., Rokita H., Walcz E., Brozik M., Hidvégi T., Merétey K. Hormonal regulation of complement biosynthesis in human cell lines--II. Upregulation of the biosynthesis of complement components C3, factor B and C1 inhibitor by interleukin-6 and interleukin-1 in human hepatoma cell line. Mol Immunol. 1990 Feb;27(2):197–201. doi: 10.1016/0161-5890(90)90115-g. [DOI] [PubMed] [Google Scholar]
  18. Falus A., Walcz E., Brozik M., Rokita H., Fust G., Hajnal A., Meretey K. Stimulation of histamine receptors of human monocytoid and hepatoma-derived cell lines and mouse hepatocytes modulates the production of the complement components C3, C4, factor B, and C2. Scand J Immunol. 1989 Aug;30(2):241–248. doi: 10.1111/j.1365-3083.1989.tb01207.x. [DOI] [PubMed] [Google Scholar]
  19. Firestein G. S., Paine M. M., Littman B. H. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum. 1991 Sep;34(9):1094–1105. doi: 10.1002/art.1780340905. [DOI] [PubMed] [Google Scholar]
  20. Gearing D. P., Comeau M. R., Friend D. J., Gimpel S. D., Thut C. J., McGourty J., Brasher K. K., King J. A., Gillis S., Mosley B. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science. 1992 Mar 13;255(5050):1434–1437. doi: 10.1126/science.1542794. [DOI] [PubMed] [Google Scholar]
  21. Graninger W. B., Hassfeld W., Pesau B. B., Machold K. P., Zielinski C. C., Smolen J. S. Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis. J Rheumatol. 1991 Oct;18(10):1621–1622. [PubMed] [Google Scholar]
  22. Hamilton J. A., Waring P. M., Filonzi E. L. Induction of leukemia inhibitory factor in human synovial fibroblasts by IL-1 and tumor necrosis factor-alpha. J Immunol. 1993 Feb 15;150(4):1496–1502. [PubMed] [Google Scholar]
  23. Harrison S. A., Mondino B. J., Mayer F. J. Scleral fibroblasts. Human leukocyte antigen expression and complement production. Invest Ophthalmol Vis Sci. 1990 Nov;31(11):2412–2419. [PubMed] [Google Scholar]
  24. Keffer J., Probert L., Cazlaris H., Georgopoulos S., Kaslaris E., Kioussis D., Kollias G. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 1991 Dec;10(13):4025–4031. doi: 10.1002/j.1460-2075.1991.tb04978.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kulics J., Colten H. R., Perlmutter D. H. Counterregulatory effects of interferon-gamma and endotoxin on expression of the human C4 genes. J Clin Invest. 1990 Mar;85(3):943–949. doi: 10.1172/JCI114523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Labowitz R., Schumacher H. R., Jr Articular manifestations of systemic lupus erythematosus. Ann Intern Med. 1971 Jun;74(6):911–921. doi: 10.7326/0003-4819-74-6-911. [DOI] [PubMed] [Google Scholar]
  27. Lachmann P. J. Complement deficiency and the pathogenesis of autoimmune immune complex disease. Chem Immunol. 1990;49:245–263. [PubMed] [Google Scholar]
  28. Lappin D. F., Birnie G. D., Whaley K. Interferon-mediated transcriptional and post-transcriptional modulation of complement gene expression in human monocytes. Eur J Biochem. 1990 Nov 26;194(1):177–184. doi: 10.1111/j.1432-1033.1990.tb19443.x. [DOI] [PubMed] [Google Scholar]
  29. Lappin D. F., Birnie G. D., Whaley K. Modulation by interferons of the expression of monocyte complement genes. Biochem J. 1990 Jun 1;268(2):387–392. doi: 10.1042/bj2680387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Lappin D. F., Guc D., Hill A., McShane T., Whaley K. Effect of interferon-gamma on complement gene expression in different cell types. Biochem J. 1992 Jan 15;281(Pt 2):437–442. doi: 10.1042/bj2810437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lappin D. F., Whaley K. Interferon-induced transcriptional and post-transcriptional modulation of factor H and C4 binding-protein synthesis in human monocytes. Biochem J. 1990 Nov 1;271(3):767–772. doi: 10.1042/bj2710767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lotz M., Moats T., Villiger P. M. Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis. J Clin Invest. 1992 Sep;90(3):888–896. doi: 10.1172/JCI115964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Moffat G. J., Lappin D., Birnie G. D., Whaley K. Complement biosynthesis in human synovial tissue. Clin Exp Immunol. 1989 Oct;78(1):54–60. [PMC free article] [PubMed] [Google Scholar]
  34. Ruddy S., Colten H. R. Rheumatoid arthritis. Biosynthesis of complement proteins by synovial tissues. N Engl J Med. 1974 Jun 6;290(23):1284–1288. doi: 10.1056/NEJM197406062902304. [DOI] [PubMed] [Google Scholar]
  35. Rönnblom L. E., Alm G. V., Oberg K. E. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med. 1991 Aug 1;115(3):178–183. doi: 10.7326/0003-4819-115-3-178. [DOI] [PubMed] [Google Scholar]
  36. Seitz M., Loetscher P., Dewald B., Towbin H., Ceska M., Baggiolini M. Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins, and prostaglandin E by rheumatoid and osteoarthritic synoviocytes--regulation by IFN-gamma and IL-4. J Immunol. 1994 Feb 15;152(4):2060–2065. [PubMed] [Google Scholar]
  37. Steinberg A. D., Steinberg B. J. Lupus disease activity associated with menstrual cycle. J Rheumatol. 1985 Aug;12(4):816–817. [PubMed] [Google Scholar]
  38. Waring P. M., Carroll G. J., Kandiah D. A., Buirski G., Metcalf D. Increased levels of leukemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 1993 Jul;36(7):911–915. doi: 10.1002/art.1780360707. [DOI] [PubMed] [Google Scholar]
  39. Waring P., Wycherley K., Cary D., Nicola N., Metcalf D. Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids. J Clin Invest. 1992 Nov;90(5):2031–2037. doi: 10.1172/JCI116083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Wilder R. L., Allen J. B., Wahl L. M., Calandra G. B., Wahl S. M. The pathogenesis of group A streptococcal cell wall-induced polyarthritis in the rat. Comparative studies in arthritis resistant and susceptible inbred rat strains. Arthritis Rheum. 1983 Dec;26(12):1442–1451. doi: 10.1002/art.1780261205. [DOI] [PubMed] [Google Scholar]
  41. Wood N. C., Symons J. A., Dickens E., Duff G. W. In situ hybridization of IL-6 in rheumatoid arthritis. Clin Exp Immunol. 1992 Feb;87(2):183–189. doi: 10.1111/j.1365-2249.1992.tb02972.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. van Eden W., Holoshitz J., Nevo Z., Frenkel A., Klajman A., Cohen I. R. Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci U S A. 1985 Aug;82(15):5117–5120. doi: 10.1073/pnas.82.15.5117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. van den Berg W. B., Joosten L. A., Helsen M., van de Loo F. A. Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin Exp Immunol. 1994 Feb;95(2):237–243. doi: 10.1111/j.1365-2249.1994.tb06517.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES